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disrupt cell function if its concentration is high enough. It is 
only the concentration that makes a thing a toxicant”. Is this 
really so? Yes, indeed: water will kill cells, kitchen salt (Na-
Cl) will kill cells, and also sugar will kill cells, if high enough 
concentrations are chosen. On the other hand, cells can live, 
proliferate, and function happily in the presence of cyanide, 
anthrax or botulinum toxins, strychnine, tetrodotoxin (TTX), 
methylmercury or E605 (parathion) and VX (a dual component 
Concentrations do matter – don’t they?
Many pharmacology and toxicology books start with the fa-
mous Paracelsus quote from the 16th century that “All things 
are poisons, for there is nothing without poisonous qualities. It 
is only the dose which makes a thing poison”. In more modern 
terms, referring to in vitro methods, this quote may be modified 
to: “all chemicals are toxic, for there is nothing that does not 
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Abstract
Some laboratory issues are taken for granted as they seem to be simple and not worth much thought. This applies to 
“concentrations of a chemical tested for bioactivity/toxicity”. Can there be any issue about weighing a compound, 
diluting it in culture medium and calculating the final mass (or particle number)-to-volume ratio? We discuss here some 
basic concepts about concentrations and their units, addressing also differences between “dose” and “concentration”. 
The problem of calculated nominal concentrations not necessarily corresponding to local concentrations (relevant 
for biological effects of a chemical) is highlighted. We present and exemplify different concentration measures, for 
instance those relying on weight, volume, or particle number of the test compound in a given volume; we also include 
normalizations to the mass, protein content, or cell number of the reference system. Interconversion is discussed as a 
major, often unresolved, issue. We put this into the context of the overall objective of defining concentrations, i.e., the 
determination of threshold values of bioactivity (e.g., an EC50). As standard approach for data display, the negative 
decadic logarithm of the molar concentrations (–log(M)) is recommended here, but arguments are also presented for 
exceptions from such a rule. These basic definitions are meant as a foundation for follow-up articles that examine the 
concepts of nominal, free, and intracellular concentrations to provide guidance on how to relate in vitro concentrations 
to in vivo doses by in vitro -to-in vivo extrapolation (IVIVE) in order to advance the use of new approach methods (NAM) 
in regulatory decision making.
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The more specific we are, the more universal something 
can become. Life is in the details. If you generalize, 
 it doesn’t resonate. The specificity of it is what resonates.
Jacqueline Woodson
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Key questions indicating the complexity  
of “concentrations”
We claim that the handling and definition of concentrations is 
less trivial than it often appears, even if issues of specificity and 
problems of deriving threshold values are left aside. The com-
plexity of the concentration concept becomes obvious when we 
try to answer the three following questions:
1. How can one define, interconvert, and compare concentra-
tions in a tissue (cell aggregate), a body fluid, and a cell 
culture medium?
2. Is it the dose (amount of compound per cell culture compart-
ment), the cell dose (the amount of compound available per 
cell) or the concentration (amount of compound per volume 
unit) that determines the toxicity threshold?
3. Is the nominal concentration of a compound a meaningful 
measure at all? Note that we must assume (without usually 
verifying this) that the compound was pure and intact before 
stocks were made, that it is stable in stocks and cell culture 
medium, that it distributes evenly, and that it does not bind to 
cell culture constituents.
Below, and in follow-up articles, we will discuss some of these 
questions, without aspirations to cover the topic comprehen-
sively. Many excellent papers have dealt with these topics, and 
only few can be mentioned (Gülden et al., 2001, 2002; Kramer 
et al., 2012, 2015; Bessems et al., 2014; Bosgra and Westerhout, 
2015; Armitage et al., 2014; Doskey et al., 2015; Groothuis et al., 
2015; Fischer et al., 2017; Wambaugh et al., 2018; Casey et al., 
2018; Bell et al., 2017). Here we attempt to make the topic 
accessible for a non-specialist community. This series of C5 ar-
ticles is intended to provide some basic insight as well as some 
handy tools that may be used immediately, without further prior 
knowledge, and not requiring extensive training.
What is a concentration?
There are some basic issues about concentrations that must be 
considered to transparently describe methods and data (Fritsche, 
2015; Bal-Price et al., 2018; Leist and Hengstler, 2018). The most 
fundamental question is the physical quantity chosen to define a 
concentration. Different disciplines have their traditions and con-
ventions, and little thought is given in the standard literature to 
these divergent approaches and the problems of interconversion. 
In all fields, a “concentration” is considered to be the ratio of (i) 
chemical and (ii) the surrounding system. The chemical may be 
expressed in terms of its volume, its mass, the number of its mol-
ecules/particles, or in terms of physical or biological properties 
such as its radioactivity. The system may be expressed as weight 
or volume. Alternatively, it may be quantified by the number or 
mass of certain molecules in the system (e.g., water, water-free 
substance, protein, DNA, or lipid). Thus, there are more than 10 
common ways to define the term “concentration”. 
The interconversion of these measures is not self-evident and 
often requires both background knowledge and additional infor-
mation. For instance, if concentration is given in ppm (parts per 
million), background information is required on what is meant 
chemical weapon), i.e., some of the deadliest poisons known. 
Viability will remain unaffected if the concentrations are below 
the toxic threshold (Krebs et al., 2018). Thus, concentrations 
do obviously matter, and this seems to be a self-evident, ap-
parently trivial fact. In practice, it is therefore astonishing how 
many problems are found in the scientific literature concerning 
the concentration concept. Of particular pharmacological-toxi-
cological interest are the following three areas:
1. How do concentrations affect specificity?
This topic will not be addressed here, but it is of eminent gener-
al importance. Compounds are quoted as being hepatotoxicants, 
neurotoxicants, reproductive toxicants, etc., but this apparent 
specificity applies only to certain concentrations (frequently 
with less than an order of magnitude between specific target 
organ and other effects, or specific effects only due to accumu-
lation in certain tissues). Similarly, compounds are classified 
as specific receptor antagonists, apoptosis inducers, antioxi-
dants, or triggers of other biological functions (Gerhardt et al., 
2001; Hansson et al., 2000; Latta et al., 2000) although only 
few chemicals show two or more orders of magnitude between 
specific and unspecific effects. Nevertheless, a screen of the lit-
erature shows that drugs, pesticides, and environmental agents 
are often used at concentrations more than orders of magnitude 
higher than their specificity threshold, or the threshold known to 
trigger human effects.
2. How is general information derived from concentration- 
response data?
In a large number of experiments, information is not sought 
for one particular concentration. Instead the question is more 
about defining a threshold concentration in a way that, e.g., 
concentrations above are considered toxic or bioactive, while 
concentrations below are considered inactive. Such threshold 
data can then have far-reaching implications, such as their use 
to define safe working concentrations or safe levels in foods. 
Such threshold values are compound-specific, and they can span 
at least 6 orders of magnitude. Note that pM concentrations of 
botulinum neurotoxin can be toxic, while high µM concentra-
tions of TTX are tolerated by nearly all cells (however, some 
cell functions may be incapacitated by nM concentrations of the 
same compound!); some compounds, such as DMSO or manni-
tol, can even be beneficial for some cells in the mM range, while 
many other chemicals would kill in this concentration range. 
Therefore, concentration thresholds have to be carefully derived 
for each given chemical. In order to set up reliable methods 
for this, there needs to be basic agreement on the definition of 
concentrations as such (see below), and on the interconversion 
of such information from one system (e.g., animals or cell cul-
tures) to another (man). Moreover, analytical measures to quan-
tify concentrations need to be established and validated (a topic 
not covered here). 
3. How are concentrations defined?
This last question is at the core of this article (and an essential 
basis for areas 1 and 2, which are not covered here explicitly), 
and we will approach it stepwise.
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patients in daily practice, e.g., patients between 50 and 150 kg 
body weight may be given the same dose of medication for blood 
pressure or asthma. Exceptions are, e.g., drug doses for children vs 
adults, or drugs with a narrow therapeutic index (anti-cancer drugs, 
some anti-epileptics, etc.). However, the normalization to body 
weight is a relatively coarse approach with multiple shortcom-
ings, and other normalizations are also common (e.g., “per body 
surface area”, or “per lean body mass”). Notably, normalized 
doses, are not to be confused with concentrations. 
Concentrations and normalized doses sound like related con-
cepts. If they are only different modes of describing similar exper-
imental conditions (physical measures), then the interconversion 
should be relatively easy. However, the concepts neither overlap, 
nor is interconversion of the measures trivial. It is in fact virtually 
impossible to convert doses to concentrations (and vice versa for 
that matter), unless a large amount of background information is 
available, and several assumptions on experimental conditions 
are made. Some approximation methods to predict concentrations 
from normalized doses will be discussed later in this series.
For the application of non-animal approaches, the concept of 
dose needs to be translated to cell cultures. In this case, there 
is no clear (generally accepted) definition of what the reference 
unit is. The two most common ones are “a cell” and “a cell cul-
ture dish”. Thus, the dose may relate to the amount of chemical 
added to a cell culture dish. As the conditions in such a dish are 
highly defined, the normalized dose appears similar to a concen-
tration, and the term “in vitro concentration-response curve” is 
frequently found in the literature. Is there really a meaningful 
difference between dose and concentration in cell cultures? 
Some examples can best clarify this: 
(1) If 1000 cells are placed in a cell culture dish in 1 ml of me-
dium, and 1 mg chemical is added, then the dose is 1 mg/
dish or 1µg/cell; the concentration is 1 mg/ml. If the same 
cells are cultured in 2 ml medium, and the same amount of 
compound is added (1 mg), then the dose is still 1 mg/dish 
and 1 µg/cell; however, the concentration is 0.5 mg/ml. 
(2) Imagine an experiment to investigate nanoparticle (NP) 
toxicity: one laboratory uses 1000 cells in 0.1 ml of medi-
um; another laboratory has a different test format, culturing 
the 1000 cells in 1 ml of medium. They both agree to use 
100,000 NP/ml. In the first lab, the cells will be exposed to 
10 NP/cell. In the second lab, cells will face 100 NP/cell.
The examples show that concentrations and normalized doses 
are different concepts. But they also indicate that the intercon-
version of a relative dose to a concentration is straightforward 
and un-complicated in vitro (relative to the large problems in 
vivo). Strictly speaking, using the term “dose-response” for new 
approach methods (NAMs) is usually incorrect, as concentra-
tion-responses are meant. Although intervonversions are rela-
tively easy, the distinction is still meaningful and relevant for the 
interpretation of data.
Are cells killed by concentrations or by doses?
The goal of many experiments in quantitative biology (biochem-
istry, physiology, pharmacology, toxicology, etc.) is to define a 
by parts (molecules, weight or volume) and what method is used 
to quantify such measures (for the system this is mostly not an 
analytical method but an assumption/historical value). Even 
more complicated are typical measures of tissue concentrations 
in vivo (applying also to in vitro microphysiological systems) 
(Hartung and Leist, 2008; Alépée et al., 2014; Gordon et al., 
2015; Marx et al., 2016): they may be given “per g wet weight”, 
“per g dry weight”, “per protein content”, “per lipid content”, 
etc. For interconversion of such measures, e.g., to molarity, 
background information is required on the protein concentration 
(for “per protein content”) or on the water-free mass per volume 
unit (for “per g dry weight”). 
Many in vivo studies (but also in vitro experiments) are per-
formed with radioactively-labelled compounds. In such cases, 
the chemical is quantified in terms of radiation released, and con-
centrations may be given in “radioactivity per gram wet weight” 
(using a unit of Bq/g). Here, at least background information 
on the specific activity of the labelled chemical is required. No-
tably, this knowledge is often not sufficient, as metabolism of 
the chemical may occur (and radioactivity may end up in the 
breakdown products), or the time-point of measurement may 
play a role (for short-lived activities). Such complexities are 
not unique to radioactivity; they essentially apply to all cases, 
where a chemical is quantified indirectly on the basis of an “ac-
tivity”, e.g., hormones, cytokines, enzymes, and toxins.
What is a dose?
From the above, it is clear that comparability of concentrations 
is not a trivial issue, and that it is essential to define such issues 
for multi-partner projects and collaborative activities. It certainly 
is also beneficial in terms of scientific communication in general. 
In this context, some fundamental decisions need to be taken on 
whether “amounts of chemical” in a system are to be expressed 
as concentrations at all. Is there an alternative to this? Yes, there 
is, and it is very important to be aware of this to avoid confusion 
and mistakes. Instead of characterizing the chemical quantity as a 
ratio of chemical and system (relative measure), the rationing may 
be omitted (absolute measure). The latter approach leads to the 
concept of “a dose”. A dose is a measured quantity of a chemical 
delivered to a system. The greater the quantity delivered, the larger 
the dose. This concept is easiest understood for medicine. The unit 
is the human body, and the dose is the amount (usually weight) 
of chemical delivered. A typical dose is packaged in a tablet. For 
instance, 500 mg of aspirin is taken as a dose (for headache) or 
10 mg zolpidem is taken as a dose (to promote sleep). The same 
applies to animals. For instance, a dose of 50 mg praziquantel may 
be given to a dog to eliminate parasites. Notably, a dose is the total 
amount delivered. 
However, doses can also be normalized to the size or the weight 
of the unit. For instance, normalized doses can be indicated in 
amount of chemical per kg body weight. In the case of the dog, 
one could specify 5 mg praziquantel per 1 kg of body weight of 
the dog. In pharmacological and toxicological research, normal-
ized doses are common to improve comparability across individ-
uals and across species. However, this is rarely applied to human 
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same is observed in the dopaminergic cell line LUHMES 
(Schildknecht et al., 2009, 2015, 2017; Efremova et al., 
2015). The import of the toxicant through the dopamine 
transporter is so efficient that a large portion of the cell 
culture medium is cleared of MPP+, and this can lead to 
a limitation of the toxicity if the overall amount (dose in 
the cell culture dish) is not sufficient to fill all cells with 
sufficient toxicant to affect cellular respiration (Pöltl et al., 
2012; Terron et al., 2018). Thus, the overall dose of MPP+ 
can play a role, in addition to its concentration. 
− The same applies to other toxicants that are strongly ac-
cumulated in cells, be it by active mechanisms (transport-
er-dependent, membrane potential-dependent) or by pas-
sive mechanisms (high affinity binding to cellular struc-
tures; accumulation in lipophilic compartments; covalent 
interactions). A typical example is methylmercury chlo-
ride. This lipophilic compound accumulates in cells and 
binds covalently to sulfhydryl groups. Therefore, cellular 
concentrations can be 100 times higher than the medium 
concentration (Zimmer et al., 2011a, 2014; Aschner et al., 
2017). Taxol is an example of cellular accumulation due to 
high affinity binding (to cellular microtubules) (Volbracht 
et al., 1999, 2001). For highly hydrophobic compounds, 
such a dieldrin, accumulation on cell culture surfaces and 
in cellular membranes may play an important role. Accu-
mulation, and thus depletion from the cell culture medium, 
may also play a role for some dyes (DNA intercalators, 
membrane stains), toxins, and compounds trapped by in-
tracellular metabolism (acetoxymethylesters).
At present, there is no ideal solution to the issue that the nomi-
nal concentration correlates well with the bioactivity for some 
but not all compounds, and dose plays an additional (or some-
times even pivotal) role. The most common procedure is to 
generally refer to concentrations, and a majority of chemicals 
dissolving well in cell culture media will be described suffi-
ciently well in this way. The overall usefulness of using nominal 
concentrations to characterize bioactivities is reflected by the 
many toxicological/pharmacological parameters that refer 
to concentrations. They include the IC50 (median inhibitory 
concentration), the EC50 (concentration evoking 50% of the 
maximal effect), the HNCC (highest non-cytotoxic concen-
tration), Cmax (peak plasma concentration), AUC (integral of 
the concentration time curve), KD (dissociation constant for a 
reversible binding process, indicated in concentration units), 
or the MAC (minimum alveolar concentration required for 
inhalation anesthesia), and many more.
Upon a more detailed analysis of the concentration concept 
(discussed in a later part of this series), it will become evident 
that so-called nominal concentrations (mathematically-deter-
mined, theoretical average concentrations in a cell culture dish) 
do not describe the respective target site concentrations. When 
methods are applied to better define the true concentrations, 
they correct for some of the distribution problems mentioned 
above, and the approach to refer to doses becomes less neces-
sary to define thresholds at which chemicals affect biological 
functions and structures.
threshold “amount” of chemical that leads to a biological effect. 
For example, such effects may be cell death, activation of a 
signaling pathway, or labeling of a structure. Back to the above 
issue: Is the right measure of the quantity of chemical a concen-
tration or a dose? Unfortunately, there is no generally correct 
answer. It depends...
In the majority of cases, concentrations are the more relevant 
physical quantity and it is most common to define biological ef-
fects of chemicals in vitro in terms of concentrations triggering 
the effect. The situation is different in vivo. Here, threshold effects 
are usually given in categories of doses or normalized doses. The 
reason is that the dose is usually easy to measure or to define, 
while concentrations in vivo are an extremely complicated con-
cept, and the data vary continuously with time and space (loca-
tion coordinates within a body). The variable ease of access and 
knowledge on the physical quantities dose vs concentration, and 
the resultant different use of these quantities is the basis of the 
fundamental problem of converting reference values from in 
vivo to in vitro, and vice versa.
Why are concentrations the most relevant  
measure in vitro? 
Most effects of chemicals are assumed to be mediated by an 
interaction of a chemical with a biological target, e.g., a recep-
tor or a stretch of DNA. Many chemical-target interactions are 
non-covalent/reversible, and they can be described by the law of 
mass action. This law is based, contrary to what may be deduced 
from its ancient name, on concentrations of chemicals. Thus, in 
most cases, the mathematical description of the bioactivity of a 
chemical is best based on concentrations.
When is this not the case? From the above, one may deduce 
that problems may arise when reactions are irreversible, or 
when a target becomes saturated so that equilibrium conditions 
are not possible. Problems with the concentration concept also 
may be found in situations where a chemical does not distrib-
ute evenly in a cell culture dish (and thus the average nominal 
concentration is not representative of the target concentration). 
Adsorption to plastic or accumulation in cell compartments 
may play a role here. Another non-equilibrium condition that 
provides problems for the concentrations concept is instability 
of a chemical, so that the time (not considered in the law of 
mass action) plays a role. The following examples show cases, 
where the dose of a chemical needs to be considered to describe 
in vitro effects: 
− In many cell cultures, hydrogen peroxide (H2O2) is elimi-
nated rapidly by the cellular catalase. If there are more cells 
(more catalase), H2O2 has a shorter half-life and thus cells 
are exposed for a shorter time to toxic concentrations. At 
higher doses (but similar concentrations), the elimination of 
H2O2 takes longer, and thus makes a given concentration 
appear more toxic. Therefore, it has been suggested to indi-
cate H2O2 toxicity in terms of cell dose (e.g., µmol H2O2 per 
1000 cells) (Gülden et al., 2010).
− Dopaminergic neurons have a high capacity to import 
the neurotoxicant methyl-phenylpyridinium (MPP+). The 
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used unambiguously without additional background information.
In biologically very complex situations (mostly referring 
to endogenous metabolites such as NADH, enzymes or RNA 
molecules) yet another approach is taken: concentrations are not 
given as absolute measures, but only as relative changes com-
pared to a control/normal situation (Kuegler et al., 2010; Zim-
mer et al., 2011b; Efremova et al., 2015; Nyffeler et al., 2018).
If one has indeed decided on the use of molarity to character-
ize the activity of chemicals, is there any guidance on the use 
of the unit (e.g., nM, µM, mM)? There is no scientific reason 
to prefer one over the other. However, there may be practical 
issues, e.g., related to data display. For instance, if compounds 
act in the µM range, indication of the numbers in mM is incon-
venient, as many zero digits need to be included, and the same 
applies vice versa. When a larger range of values is covered, 
logarithmic scaling is useful. For instance, if all values are given 
in log molarity (log(M)), large ranges can be covered (Krebs et 
al., 2018), and this approach allows keeping numbers in an easy 
(convenience for human users) format with one pre-comma dig-
it. However, all numbers will be negative (one µM will be -6, 
one mM will be -3). It may be inconvenient to use negative 
numbers throughout. For this reason, the use of -log(M) is com-
mon for large chemical screens in pharmaceutical industry. The 
latter could be a universal data format to be used for most ap-
plications. The only disadvantage is that graphical data display 
usually follows the convention that small numbers are on the 
left side of the x-axis, and large numbers are right. To follow 
this tradition, one has to accept that 9 (referring to 1 nM) is 
a smaller number than 3 and use a data display program that 
can deal with this condition. Alternatively, one must become 
accustomed to curves looking different from the usual text-book 
display (horizontal mirroring). 
In summary, the following example compiles the above dis-
cussion: In a given cell culture system, the toxicity (EC50) of the 
three toxicants A, B, and C may be 6.0 (given in -log(M)). This 
means that a nominal concentration of 1 µM kills or impairs 
50% of the cells. If the compounds have molecular weights of 
100, 500, and 2500 Dalton, then the toxicity expressed in µg/ml 
would differ by factors of 5 and 25. Another potential difference 
may be that the toxicity of compounds A and B may be 6.0, 
independent of the plate format and cell number used, while the 
toxicity of C may be 4.0 in another culture dish with higher cell 
numbers. 
Outlook
Three further issues need a future dedicated discussion: (i) the 
nominal concentration of a chemical may not correlate with its 
free bioactive concentration in cell culture medium (Blaauboer 
et al., 2012; Westerhout et al., 2011); (ii) the concentration of a 
toxicant inside a cell, where the chemical’s target is located, may 
not correlate with its free medium concentration; (iii) the thresh-
old concentration determined in vitro may need to be converted 
to the respective in vivo concentration, or possibly to a dose that 
results in such a concentration. The procedure to predict such 
Suitable measures of concentrations
If, and when, concentrations are measured to derive import-
ant summary and threshold data, then an important practical 
question arises: What is the most useful quantity definition, 
i.e., which type of unit should be used? The first type of con-
sideration concerns the type of unit, i.e., the preferred physical 
measure, such as fraction (ppm), weight per volume (mg/ml), or 
molarity (particles per volume; mM). In toxicology and phar-
macology, there is a strong case for using molarity, as this has a 
clear definition (as opposed to ppm), does not require additional 
background knowledge/information, and allows direct compari-
son of numbers (as opposed to weight/volume units). 
− In a test reacting specifically to lithium ions, the threshold 
molarity would be the same for the chloride, mesylate, or 
iodide salts, and it would be independent of whether the crys-
tals contain two or six water molecules per unit. If, however, 
the threshold value is given in µg/ml, it will be different for 
all these ways to solubilize lithium ions. 
− If one compares the toxicity of polychlorinated biphenyls 
in weight/volume units, then the highly chlorinated (high 
molecular weight) congeners will always appear to be less 
toxic, while expression of the EC50 in molarity compares the 
same numbers of molecules, and thus is scientifically more 
appropriate (Nyffeler et al., 2018). 
− For screening, often an upper level (a highest screened 
concentration) is defined (Nyffeler et al., 2017; Delp et al., 
2018). For instance, all compounds are screened up to a con-
centration of 50 µM or up to 50 µg/ml. In the latter case (50 
µg/ml), one would screen low molecular weight compounds 
at much higher molar concentrations than high molecular 
weight compounds. This would lead to a misrepresentation 
of the bioactivities. 
So, what are reasons to still use weight/volume measures? For 
most applications, there is no good reason besides tradition 
and practical convenience. Convenience refers to the issue that 
preparation of weight/volume stock solutions is always possi-
ble, even without knowing molecular weight or the purity of a 
compound. Thus, such approaches are well justified for unde-
fined extracts, mixtures of compounds, substances of unknown 
molecular weight, etc. They must be employed in cases in which 
molarity cannot be calculated. However, it is hard to understand 
why this approach would be transferred to areas where exact 
information on the molecular weight and compound purity is 
available, and thus molarities can be calculated.
In some fields, an alternative to the use of molarities is the use 
of unitless fractions (%, ppm, ppb, etc.). These may be useful 
for non-aqueous systems, for which the use of molarities is un-
common, e.g., mixtures of gases or solvents, contaminants in 
metals and chemicals within solid feed (used for feeding studies 
in toxicology). The practical problem here is that it is not evident 
whether the ratios refer to volumes, weights or particle numbers, 
and different fields use different rules and definitions. It is clear 
that for most experimental systems (combination of a chemical 
with its background substance) a volume percentage will not be 
the same as a weight percentage, and thus these units cannot be 
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